Nynomic AG Shows Signs of Recovery Amid Challenging Conditions

Nynomic AG, an innovative company in the high-tech sector, recently published its Q3 preliminary results, revealing mixed performance. The company reported Q3 sales of €22.8 million, which is a 6.3% decline compared to last year. This downturn is attributed to ongoing weak demand in end markets, which has been exacerbated by supply chain issues such as rare earth trade restrictions and semiconductor shortages. These factors have delayed revenue recognition and affected all segments of Nynomic AG.

On a more positive note, the company experienced the highest order intake since Q1 2024, with €27.9 million, marking a 44% increase. This increase points to Nynomic having potentially moved past its demand trough. Furthermore, the company's EBIT has turned positive for the first time in two quarters, standing at €0.5 million.

Despite trimming its FY25 sales guidance, Nynomic expects to benefit from its ongoing efficiency program “NyFit2025.” This initiative is anticipated to bring significant cost savings and improved profitability in the coming years. Consequently, NuWays AG has maintained a "Buy" rating for Nynomic AG, albeit with a revised target price of €21.